Development of highly potent phosphodiesterase 4 inhibitors with anti-neuroinflammation potential: Design, synthesis, and structure-activity relationship study of catecholamides bearing aromatic rings-Reference-Cited by-同舟云学术

Development of highly potent phosphodiesterase 4 inhibitors with anti-neuroinflammation potential: Design, synthesis, and structure-activity relationship study of catecholamides bearing aromatic rings

Published:2016-11 Issue: Volume:124 Page:372-379
ISSN:0223-5234
Container-title:European Journal of Medicinal Chemistry
language:en
Short-container-title:European Journal of Medicinal Chemistry

Author:

Zhou Zhong-Zhen^ORCID,Ge Bing-Chen,Zhong Qiu-Ping,Huang Chang,Cheng Yu-Fang,Yang Xue-Mei,Wang Hai-Tao,Xu Jiang-Ping

Funder

Foundation for Guangdong Distinguished Young Teachers in Higher Education of China

Science and Technology Program of Guangdong Province of China

National Science and Technology

NSFC-Guangdong Joint Fund

National Natural Science Foundation of China

Publisher

Elsevier BV

Subject

Organic Chemistry,Drug Discovery,Pharmacology,General Medicine

Reference22 articles.

1. Phosphodiesterase-4 inhibitors: a review of current developments (2010-2012);Gavalda;Expert Opin. Ther. Pat.,2013

2. Recent advances on phosphodiesterase 4 inhibitors for the treatment of asthma and chronic obstructive pulmonary disease;Kodimuthali;J. Med. Chem.,2008

3. Phosphodiesterases as therapeutic targets for Alzheimer's disease;Garcia-Osta;ACS Chem. Neurosci.,2012

4. Roflumilast: the new orally active, selective phophodiesterase-4 inhibitor, for the treatment of COPD;Tashkin;Expert Opin. Pharmacother.,2014

5. Apremilast: a PDE4 inhibitor for the treatment of psoriatic arthritis;Abdulrahim;Expert Opin. Pharmacother.,2015

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Discovery of 7-alkoxybenzofurans as PDE4 inhibitors with hepatoprotective activity in D-GalN/LPS-induced hepatic sepsis;European Journal of Medicinal Chemistry;2024-09

2. PDE4D: A Multipurpose Pharmacological Target;International Journal of Molecular Sciences;2024-07-24

3. Targeting cAMP signaling and phosphodiesterase 4 for liver disease treatment;Medicinal Chemistry Research;2024-06-26

4. Opportunities and perspectives of small molecular phosphodiesterase inhibitors in neurodegenerative diseases;European Journal of Medicinal Chemistry;2024-05

5. Design, Synthesis, Biological Evaluation and Docking Study of A New Series of 9‐aminoacridine Derivatives as Anti‐inflammatory Agents;ChemistrySelect;2024-01-23